Calcilytix has 11-50 employees.
calcilytix
calcilytix therapeutics inc
calcilytix therapeutics
Departments
Number of employees
Operations
4
Medical & Health
3
Legal
2
Engineering & Technical
1
Sales
1
C-Suite
1
| Location | People at location |
| North America | 1-10 |
BridgeBio Pharma is dedicated to improving the lives of individuals with Autosomal Dominant Hypocalcemia Type 1 (ADH1) through the development of Encaleret, an investigational oral treatment targeting calcium-sensing receptor gene. ADH1 is a common genetic condition characterized by hypoparathyroidism caused by gain-of-function variants in the CASR... Read More